Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
How It Works 
News - Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI Summary - About
BlackRock Health Sciences Trust(BME)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Stock price based on last close Advisory Performance History (Simulated)
Upturn Advisory & Investor View for BME
11/06/2026: BME (3-star) is a STRONG-BUY. BUY for 11 days. Simulated Profits (3.90%). Updated daily EoD!
BlackRock Health Sciences Trust is a closed-end fund designed to provide investors with exposure to the healthcare sector while generating monthly income through an equity and option-writing strategy. Its primary strength lies in professional management that balances growth-oriented healthcare stocks with income-generating derivatives. The core investment story centers on capturing long-term growth from innovation in medicine and demographic-driven demand. However, risks include sensitivity to regulatory changes in drug pricing and potential share price discounts to net asset value. This fund may suit income-focused investors who desire healthcare exposure, provided they are willing to monitor the regulatory environment and potential volatility associated with closed-end funds.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Mixed fit | The focus is on healthcare, which is a growth-oriented sector, though the fund's income strategy may dampen capital appreciation. |
| Momentum investor | Weak fit | Closed-end funds generally lack the high-velocity price action favored by momentum strategies. |
| Value investor | Mixed fit | Value investors may find appeal if the fund trades at a significant discount to its net asset value. |
| Dividend investor | Strong fit | The fund's core objective of providing current income through distributions makes it highly suitable for income-focused investors. |
| Low-risk investor | Mixed fit | Healthcare is relatively defensive, but equity market exposure and option strategies carry inherent risks. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | Medium | The share price is subject to both the volatility of healthcare stocks and market sentiment regarding closed-end funds. |
| Valuation risk | Medium | The fund may trade at a premium or discount to its net asset value, impacting total return. |
| Competition risk (ETF substitution) | Medium | Low-cost healthcare ETFs provide intense competition for investment capital. |
| Business quality | Strong | The fund benefits from the established institutional backing and management expertise of BlackRock. |
| Dividend income | Medium / high | The ability to sustain distributions depends on market conditions and the success of the option-writing strategy. |
| Execution risk | Low | BlackRock's long history in managing closed-end funds reduces operational execution risk. |
Price Behavior
Strong Uptrend
The stock has maintained a strong upward price trend across the last three quarters.
Very Smooth
The stock has followed a highly orderly price path with minimal short-term disruption.
Analysis of Past Performance
Type Stock | Historic Profit 40.72% | Avg. Invested days 69 | Today’s Advisory Strong Buy |
Upturn Advisory Rating  | Upturn Advisory Performance  4.0 | Stock Returns Performance  3.0 |
| Profits based on simulation | Last Close 11/06/2026 |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals
Financial Health Rating
Growth Momentum Score
Ownership
Unit Economics (Per $1K Revenue)
Economic Dimensions
Quantitative Style Profile
Style Classification
Quality Focused
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 605.75M USD | Price to earnings Ratio 5.82 | 1Y Target Price - |
Price to earnings Ratio 5.82 | 1Y Target Price - | ||
Volume (30-day avg) 44.0K shares | Beta 0.59 | 52 Weeks Range 35.91 - 48.30 | Updated Date 11/08/2026 |
52 Weeks Range 35.91 - 48.30 | Updated Date 11/08/2026 | ||
Dividends yield (FY) 6.76% | Basic EPS (TTM) 8.06 |
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Portfolio Management | Investment in healthcare equities (pharmaceuticals, biotech, medical devices). | The fund earns money by holding stocks that grow in value and pay dividends. |
| Option Writing | Selling call options on portions of the portfolio. | The fund earns extra cash by selling options, which is then used to pay your monthly dividends. |
Valuation
Trailing PE 5.82 | Forward PE - | Enterprise Value 606.44M | Price to Sales(TTM) 6.24 |
Enterprise Value 606.44M | Price to Sales(TTM) 6.24 | ||
Enterprise Value to Revenue 5.8 | Enterprise Value to EBITDA - | Shares Outstanding 12.92M | Shares Floating - |
Shares Outstanding 12.92M | Shares Floating - | ||
Percent Insiders - | Percent Institutions 20.14 |
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.